Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Pediatric Hematology/Oncology
ISTH 2025
Questions discussed in this category
What are your top takeaways from ISTH 2025?
2 Answers available
24822
Papers discussed in this category
Journal of thrombosis and haemostasis : JTH, 2025 Jun 17
2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura.
Lancet (London, England), 2025 Mar 01
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.
Blood, 2024 Oct 03
Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange.
Related Topics in Pediatric Hematology/Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers
